Advances in Stroke-Immunology: From Molecular Mechanisms to Clinical Translation

Advances in Stroke-Immunology: From Molecular Mechanisms to Clinical Translation is organized by European Molecular Biology Organization (EMBO) and will be held from Apr 27 - 30, 2026 at Schloss Hohenkammer, Hohenkammer, Bavaria, Germany.

About the Workshop:
Immune responses are central to the pathophysiology of stroke, influencing both acute injury and long-term recovery. While stroke has traditionally been viewed as a neurological event, it is now clear that it initiates a dynamic and systemic immune response that extends far beyond the brain. Recent advances in neuroimmunology have demonstrated critical roles for microglia, leukocyte trafficking, and immune alterations in peripheral organs such as the gut, heart, and meninges. Cutting-edge technologies—including single-cell RNA sequencing and spatial transcriptomics—are now revealing the complex cellular and functional heterogeneity of these immune responses. These new findings have catalyzed a wave of translational research, with clinical trials underway to modulate the immune system for improved stroke outcomes. Moreover, the immune mechanisms in stroke share parallels with those in aging and other neurodegenerative conditions, highlighting their broader relevance. Yet, fundamental questions remain about how peripheral immune cells, brain-resident glial cells, and neurons interact between each other to shape injury and repair.
The goal of this EMBO Workshop is to bring together leading experts, emerging investigators, and early-career scientists to explore these questions and share the latest breakthroughs in stroke-immunology. By fostering cross-disciplinary discussion and collaboration, we aim to accelerate the development of novel therapeutic strategies that harness the immune system to promote brain repair and improve recovery after stroke.